Colorado-based premium marijuana infused products maker Dixie Brands has been busy lately, announcing new products as well as expansion plans in several states and Australia for its core business, but it has also extended its brand into two different areas.  In August, it announced the launch of Aceso, which uses industrial hemp as an input to obtain CBD and other cannabinoids and terpenes for health and wellness products, and Therabis, which does the same except targeting companion animals. Chief Marketing Officer Joe Hodas discussed these developments in September, and now the company has officially launched both lines of products.

Aceso, which is named after the Greek goddess of healing, manufactures its products in Denver and can ship them to all 50 states and to most countries.  The company uses industrial hemp grown in Europe. The company lab tests all of the hemp extracts and batch tests its products. The products contain between 5ng and 7.5mg per serving. Products include:

• Calm, a 1 oz spray that contains 335mg of CBD and includes terpenes linalool and limonene, passionflower extract and COQ10 (with an additional formulation to be launched)
• Soothe, a 1 oz spray that contains 335mg of CBD and includes terpene beta-carophyllene along with cinnamon extract, tart cherry, turmeric and bromelain (with an additional formulation to be launched)
• Wellness, a 1 oz spray that contains 335mg of CBD and includes terpene limonene, capsaicin and green tea (with an additional formulation to be launched)

New York veterinarian Stephen Katz teamed up with Dixie Brands to create Therabis, which is now marketing three different formulations for dogs initially.  Each product targets the size of the dog and is available in either 5 or 30 servings.  The products contain CBD and are sprinkled onto the pet’s food.

• Stop the Itch contains bromelain and quercetin
• Calm and Quiet contains l-theanine and chromium
• Up and Moving contains green-lipped mussel, chromium, vitamin C and vitamin E

Both companies are offering free shipping through 11/30.

Exclusive article by Alan Brochstein, CFA

Based in Houston, Alan leverages his experience as founder of online community 420 Investor, the first and still largest due diligence platform focused on the publicly-traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. At New Cannabis Ventures, he is responsible for content development and strategic alliances. Before shifting his focus to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst following over two decades in research and portfolio management. A prolific writer, with over 650 articles published since 2007 at Seeking Alpha, where he has 70,000 followers, Alan is a frequent speaker at industry conferences and a frequent source to the media, including the NY Times, the Wall Street Journal, Fox Business, and Bloomberg TV. Contact Alan: Twitter | Facebook | LinkedIn | Email